In this issue:
Sintilimab plus P-GEMOX
5-year final analysis on Ro-CHOP trial
FLT3-mutated AML plus gilteritinib
Survival of elderly HL patients
Effect of CAR-T cell infusion delays
Comparing axi-cel to immunotherapy
Comparison of axi-cel in PMBCL and other LBCLs
Biomarkers to predict toxicity and outcomes of CAR-T therapies
iPET for cHL patients
Safety profile of venetoclax and hypomethylating agents
Please login below to download this issue (PDF)